# Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung Cancer

> **NCT06406608** · NA · RECRUITING · sponsor: **Henan Cancer Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **OTHER:** Chemotherapy and targeted-therapy guided by organoid drug sensitivity test

## Key facts

- **NCT ID:** NCT06406608
- **Lead sponsor:** Henan Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-16
- **Primary completion:** 2025-12-16
- **Final completion:** 2026-06-16
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06406608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06406608, "Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06406608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*